Literature DB >> 28002410

DNA repair: A unifying mechanism in neurodegeneration.

Christopher A Ross1, Ray Truant1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 28002410     DOI： 10.1038/nature21107

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

1.  Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.

Authors:  M A Lovell; S P Gabbita; W R Markesbery
Journal:  J Neurochem       Date:  1999-02       Impact factor: 5.372

2.  A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases.

Authors:  Kyota Fujita; Yoko Nakamura; Tsutomu Oka; Hikaru Ito; Takuya Tamura; Kazuhiko Tagawa; Toshikazu Sasabe; Asuka Katsuta; Kazumi Motoki; Hiroki Shiwaku; Masaki Sone; Chisato Yoshida; Masahisa Katsuno; Yoshinobu Eishi; Miho Murata; J Paul Taylor; Erich E Wanker; Kazuteru Kono; Satoshi Tashiro; Gen Sobue; Albert R La Spada; Hitoshi Okazawa
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 3.  In vivo aspects of protein folding and quality control.

Authors:  David Balchin; Manajit Hayer-Hartl; F Ulrich Hartl
Journal:  Science       Date:  2016-07-01       Impact factor: 47.728

Review 4.  Neurological disorders associated with DNA strand-break processing enzymes.

Authors:  Bingcheng Jiang; J N Mark Glover; Michael Weinfeld
Journal:  Mech Ageing Dev       Date:  2016-07-25       Impact factor: 5.432

Review 5.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

Review 6.  DNA oxidation in Alzheimer's disease.

Authors:  William R Markesbery; Mark A Lovell
Journal:  Antioxid Redox Signal       Date:  2006 Nov-Dec       Impact factor: 8.401

7.  Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease.

Authors:  Xiao-Hong Lu; Virginia B Mattis; Nan Wang; Ismael Al-Ramahi; Nick van den Berg; Silvina A Fratantoni; Henry Waldvogel; Erin Greiner; Alex Osmand; Karla Elzein; Jingbo Xiao; Sipke Dijkstra; Remko de Pril; Harry V Vinters; Richard Faull; Ethan Signer; Seung Kwak; Juan J Marugan; Juan Botas; David F Fischer; Clive N Svendsen; Ignacio Munoz-Sanjuan; X William Yang
Journal:  Sci Transl Med       Date:  2014-12-24       Impact factor: 17.956

8.  Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease.

Authors: 
Journal:  Cell       Date:  2015-07-30       Impact factor: 41.582

9.  XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia.

Authors:  Nicolas C Hoch; Hana Hanzlikova; Stuart L Rulten; Martine Tétreault; Emilia Komulainen; Limei Ju; Peter Hornyak; Zhihong Zeng; William Gittens; Stephanie A Rey; Kevin Staras; Grazia M S Mancini; Peter J McKinnon; Zhao-Qi Wang; Justin D Wagner; Grace Yoon; Keith W Caldecott
Journal:  Nature       Date:  2016-12-21       Impact factor: 49.962

10.  DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases.

Authors:  Conceição Bettencourt; Davina Hensman-Moss; Michael Flower; Sarah Wiethoff; Alexis Brice; Cyril Goizet; Giovanni Stevanin; Georgios Koutsis; Georgia Karadima; Marios Panas; Petra Yescas-Gómez; Lizbeth Esmeralda García-Velázquez; María Elisa Alonso-Vilatela; Manuela Lima; Mafalda Raposo; Bryan Traynor; Mary Sweeney; Nicholas Wood; Paola Giunti; Alexandra Durr; Peter Holmans; Henry Houlden; Sarah J Tabrizi; Lesley Jones
Journal:  Ann Neurol       Date:  2016-05-06       Impact factor: 10.422
  10 in total
  20 in total

Review 1.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

2.  DNA damage and neurodegenerative phenotypes in aged Ciz1 null mice.

Authors:  Mohammad Moshahid Khan; Jianfeng Xiao; Damini Patel; Mark S LeDoux
Journal:  Neurobiol Aging       Date:  2018-02       Impact factor: 4.673

3.  LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease.

Authors:  Evan H Howlett; Nicholas Jensen; Frances Belmonte; Faria Zafar; Xiaoping Hu; Jillian Kluss; Birgitt Schüle; Brett A Kaufman; J T Greenamyre; Laurie H Sanders
Journal:  Hum Mol Genet       Date:  2017-11-15       Impact factor: 6.150

4.  DNA Double-Strand Break Accumulation in Alzheimer's Disease: Evidence from Experimental Models and Postmortem Human Brains.

Authors:  Nidheesh Thadathil; David F Delotterie; Jianfeng Xiao; Roderick Hori; Michael P McDonald; Mohammad Moshahid Khan
Journal:  Mol Neurobiol       Date:  2020-09-08       Impact factor: 5.590

5.  Associations of rs823128, rs1572931, and rs823156 polymorphisms with reduced Parkinson's disease risks.

Authors:  Ye Bai; Lihong Dong; Xinghua Huang; Shuanglin Zheng; Ping Qiu; Fenghua Lan
Journal:  Neuroreport       Date:  2017-09-27       Impact factor: 1.837

6.  Poly(ADP-ribosylation) is present in murine sciatic nerve fibers and is altered in a Charcot-Marie-Tooth-1E neurodegenerative model.

Authors:  Laura I Lafon Hughes; Carlos J Romeo Cardeillac; Karina B Cal Castillo; Salomé C Vilchez Larrea; José R Sotelo Sosa; Gustavo A Folle Ungo; Silvia H Fernández Villamil; Alejandra E Kun González
Journal:  PeerJ       Date:  2017-05-10       Impact factor: 2.984

Review 7.  Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins.

Authors:  Jesús Avila; María Llorens-Martín; Noemí Pallas-Bazarra; Marta Bolós; Juan R Perea; Alberto Rodríguez-Matellán; Félix Hernández
Journal:  Front Neurosci       Date:  2017-11-10       Impact factor: 4.677

8.  Genome-Wide Screen of the Hippocampus in Aged Rats Identifies Mitochondria, Metabolism and Aging Processes Implicated in Sevoflurane Anesthesia.

Authors:  Yujie Wang; Min Qian; Yinyin Qu; Ning Yang; Bing Mu; Kaixi Liu; Jing Yang; Yang Zhou; Cheng Ni; Jing Zhong; Xiangyang Guo
Journal:  Front Aging Neurosci       Date:  2020-05-07       Impact factor: 5.750

9.  PARP inhibitors protect against sex- and AAG-dependent alkylation-induced neural degeneration.

Authors:  Mariacarmela Allocca; Joshua J Corrigan; Kimberly R Fake; Jennifer A Calvo; Leona D Samson
Journal:  Oncotarget       Date:  2017-08-03

10.  Complementation of aprataxin deficiency by base excision repair enzymes in mitochondrial extracts.

Authors:  Melike Çaglayan; Rajendra Prasad; Rachel Krasich; Matthew J Longley; Kei Kadoda; Masataka Tsuda; Hiroyuki Sasanuma; Shunichi Takeda; Keizo Tano; William C Copeland; Samuel H Wilson
Journal:  Nucleic Acids Res       Date:  2017-09-29       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.